• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Tetraphase Pharmaceuticals Inc

+ Add to Watchlist

TTPH:US

18.4300 USD 0.3300 1.82%

As of 10:42:33 ET on 09/23/2014.

Snapshot for Tetraphase Pharmaceuticals Inc (TTPH)

Open: 18.0000 Day's Range: 18.0000 - 18.7400 Volume: 114,583
Previous Close: 18.1000 52wk Range: 8.0100 - 18.7400 1-Yr Rtn: +64.04%

Stock Chart for TTPH

No chart data available.
  • TTPH:US 18.4242
  • 1D
  • 1M
  • 1Y
18.1000
Interactive TTPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TTPH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.2200
Est. EPS (USD) (12/2014) -2.3680
Est. PEG Ratio -
Market Cap (M USD) 469.75
Shares Outstanding (M) 25.95
30 Day Average Volume 403,019
Price/Book (mrq) 8.1372
Price/Sale (ttm) 55.3910
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TTPH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TTPH

Tetraphase Pharmaceuticals, Inc. biopharmaceutical products. The Company offers antibiotics to treat multi-drug resistant bacterial infections. Tetraphase Pharmaceuticals serves customers in the United States.

Guy MacdonaldPresident/CEOJ Craig ThompsonChief Operating Officer
Patrick T HornChief Medical OfficerDavid C LubnerSenior VP/CFO
More Company Profile & Key Executives for TTPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil